Rib-X Pharmaceuticals, Inc. owns full commercialization rights to all of its product development and discovery programs. As these programs mature during the next few years, we will look to identify strategic partnerships for some of our programs. These collaborations will provide funding to advance our internal antibiotic drug discovery and clinical development programs and accelerate our growth into a commercial organization. Rib-X has the ability to enter into a wide variety of partnership agreements focused on our antibiotic research & discovery capabilities, development of existing compounds, and commercialization of our late stage clinical programs.